{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Famindr.com%2Fepisodes%2F27-novel-drug-development-part-3-alzheimers-disease-june-2020-9aIUpA8G","width":444,"version":"1.0","type":"rich","title":"27 - Novel Drug Development - Part 4: Alzheimer's Disease June 2020","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/9a8ef428-72db-47cb-a5cb-a6a258a13785/e711d400-4be1-41f3-b4fc-b9afbaf4ca1b/slide1.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/d8da9b97-cdb2-4405-8be2-25ed6efc8a9a\" height=\"200\" width=\"100%\" title=\"27 - Novel Drug Development - Part 4: Alzheimer&apos;s Disease June 2020\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"Having trouble keeping up with the literature in Alzheimer's Disease? We are here to help! \n\nJoseph tells you about more papers on drugs in development from June 2020.   These studies encompass those done in vitro or using computational models, but not animal testing. This episode brings together abstracts that were not sorted into a specific target cluster, so you will hear about a variety of treatment targets such as histone deacetylase, caspase-6, monoamine oxidase, microRNA, and more!"}